All lobbying filings

S-3 GROUP

Lobbying for WALGREEN COMPANY · Pharmacy-led, health and wellbeing retail company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 17, 2026

Official filing document

Bills named in this filing 2

HR 2853
Combating Organized Retail Crime Act of 2025
S 1404
Combating Organized Retail Crime Act

Lobbying activity 3

Medicare/Medicaid

Issues related to the provider status of pharmacists under Medicare Part B

Pharmacy

Issues related to pharmacy, pharmacist provider status, pharmacy benefit managers, Medicare reimbursement, and pharmaceutical supply chain transparency

Consumer Issues/Safety/Products

Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.